Neil James Clarke

Title: Innovations by Neil James Clarke: A Pioneer in Antigen Binding Proteins

Introduction

Neil James Clarke is an accomplished inventor based in Stevenage, GB, known for his significant contributions to the field of biotechnology. His expertise in developing innovative solutions is exemplified in his patent related to antigen binding proteins.

Latest Patents

Neil holds a patent for "Antigen binding proteins," which pertains to antibodies that specifically bind to HER3. This patent also covers polynucleotides encoding such proteins, as well as pharmaceutical compositions that incorporate these antigen binding proteins. The disclosure emphasizes the potential of these proteins in treating or preventing a variety of cancers, such as breast, ovarian, prostate, bladder, pancreatic, gastric, melanoma, and other cancers associated with HER3 overexpression.

Career Highlights

He is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he utilizes his skills in innovation to further research and development efforts. Neil’s work focuses on creating advancements that may lead to significant breakthroughs in cancer treatment and therapy.

Collaborations

Collaboration is key in any field of innovation. Neil has worked alongside talented colleagues such as Kyung Oh Johanson and Zdenka Ludmila Jonak. Together, they contribute towards enhancing the scope of cancer therapies and improving patient outcomes through their collective expertise.

Conclusion

Neil James Clarke's dedicated work in the area of antigen binding proteins marks him as an influential figure in biotechnology. His patent not only demonstrates his innovative spirit but also paves the way for potential advancements in the treatment of various cancers, showcasing the impact of his work in fighting serious health challenges.